Med-tech company Medtronic (MDT) announced on Tuesday that its board of directors has appointed industry veterans John ...

Medtronic (MDT) recently reported its Q1 FY2026 earnings, showing an increase in sales to $8,578 million, while net income ...

Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

Medtronic (MDT) stock in focus as the company raises FY2025 earnings outlook amid Q1 outperformance and reduced tariff impact ...

Medtronic PLC (MDT) reports robust growth across key segments, raises full-year EPS guidance, and outlines strategic ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Medtronic develops and manufactures a wide range of medical devices, including implantable cardiac pacemakers, heart valves, neurostimulation systems, insulin pumps, and surgical robotics platforms.

Medtronic (NYSE:MDT) reports Q1 earnings on Aug 19. Can it sustain revenue growth amid EPS concerns? Learn about key trends, ...

The medical device company posted revenue of $8.58 billion in the period, also beating Street forecasts. Eleven analysts surveyed by Zacks expected $8.37 billion. Medtronic expects full-year earnings ...

Medtronic’s adjusted operating margin slid 40 bps to 24.4% in Q1. Medtronic’s bottom line of $1.23 on an adjusted basis was slightly above the $1.20 figure it reported in the prior-year quarter.

In the first quarter of fiscal year 2026, Medtronic saw growth in its overall revenue and neuroscience portfolio, according to financial results posted Aug. 19. Five things to know: 1. Total revenue ...

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...